Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | XXII 0.1977 -8.34% | SHFS 0.1324 -61.39% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | YFOR 0.2236 -1.58% | RBNE 0.19 -2.56% | TQQQ 66.29 -0.20% | VZ 44.66 -1.19% | TSLL 9.76 -1.21% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | SQQQ 39.68 0.20% | AIOK 12.02 182.82% | ONDS 6.2 2.99% | AAPL 347.725 -0.14% | LABT 0.31 -36.67% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | GRAB 2.79 -2.11% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | IREN 24.905 -2.37% | QID 14.55 0.14% | RKT 11.73 -0.09% | WULF 11.32 0.00% | BE 193.3 -11.24%
APAptose Biosciences Inc. logo

Aptose Biosciences Inc. (APTO)

NASDAQ Capital Market · Currency in USD
$1.71 ▲ +1.71 (+100.00%)
At close: Feb 10, 4:00 PM ET. Market closed.

Summary

Previous Close
$1.71
Open
$1.71
Day's Range
$1.71 – $1.71
52 Week Range
$1.10 – $43.19
Volume
648,213
Avg. Volume
223,276
Market Cap
$4.36M
Beta (5Y Monthly)
1.13
PE Ratio (TTM)
--
EPS (TTM)
$2.17
Earnings Date
--
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
--

Profile: Aptose Biosciences Inc.

Sector
Healthcare
Industry
Biotechnology
Full-time employees
35
CEO
William G. Rice
Website
aptose.com

Aptose Biosciences Inc. operates as a clinical-stage biopharmaceutical enterprise, dedicated to discovering and advancing personalized therapeutic solutions to address critical unmet medical needs within the field of oncology, primarily focusing on the United States market. Its active clinical pipeline features several promising candidates. APTO-253 is currently undergoing Phase 1a/b clinical evaluation for patients battling relapsed or treatment-resistant blood cancers, including acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (HR MDS).

Earnings

DateEst.Actual
Mar 28, 2025-$1.21-$9.52Miss
Nov 8, 2024-$19.20-$11.11Beat
Aug 8, 2024-$17.42-$12.91Beat
May 14, 2024-$0.82-$21.92Miss
Mar 26, 2024-$1.59-$43.24Miss
Nov 9, 2023-$64.86-$1.76Beat

Analyst view

Rating: Buy
Buy 91% · Hold 9% · Sell 0%

Get free alerts on APTO and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.